OncNGS
  • Home
  • Call for tenders
  • About OncNGS
  • Phases
    • Pre-commercial Procedure
    • Phase 0 : Curiosity Driven Research
    • Open Market Consultation
    • Phase I : Solution design
    • Phase II: Prototype development
    • Phase III : Clinical validation of a limited set of pre-commercial devices
  • Matchmaking: find a partner!
  • FAQ
  • News
  • Contact
  • Workspace
  • Home
  • Call for tenders
  • About OncNGS
  • Phases
    • Pre-commercial Procedure
    • Phase 0 : Curiosity Driven Research
    • Open Market Consultation
    • Phase I : Solution design
    • Phase II: Prototype development
    • Phase III : Clinical validation of a limited set of pre-commercial devices
  • Matchmaking: find a partner!
  • FAQ
  • News
  • Contact
  • Workspace

Phase II: Prototype development

Phase 2 suppliers will develop their solution and demonstrate their analytical validity having followed the Analytical test plan approved in Phase 1. The Analytical validation will consist of demonstration of assay performance (accuracy, precision, specificity, etc.). During Phase 2, suppliers will be requested to deliver the clinical validation protocol of the pre-commercial devices and Data Management Plan (‘DMP’) (including patients’ consents) they will perform in Phase 3.

At the end of the Phase 2, the invitation to Phase 3 (call-off) will be issued.

Overall duration: 15 months

Execution : 12 months

Other phases

Pre-commercial Procedure
Phase 0 : Curiosity Driven Research
Phase I : Solution design
Phase III : Clinical validation of a limited set of pre-commercial devices

This project has received funding from the European Union’s Horizon 2020 research and innovation programme under grant agreement No 874467

Follow us :

© OncNGS

  • Privacy policy
  • Disclaimer